EPISODE · Apr 20, 2026 · 38 MIN
Biotech Breakthroughs: Gene Editing Moves Beyond the Hype
from The William Blair Thinking Podcast
In this episode of Biotech Breakthroughs, Matt Phipps, group head of biotech research, speaks with William Blair biotech analyst Myles Minter about how gene editing is moving from early hype toward clinically validated therapies. They discuss lessons from the first approved ex vivo product and highlight key 2026 catalysts across CRISPR, base editing, RNA editing, and DNA writing.
Embed this episode
Ready to play
Biotech Breakthroughs: Gene Editing Moves Beyond the Hype
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.